NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|31542309|ref|NP_055733|]
View 

chondroitin sulfate synthase 1 [Homo sapiens]

Protein Classification

chondroitin N-acetylgalactosaminyltransferase family protein( domain architecture ID 10418577)

chondroitin N-acetylgalactosaminyltransferase family protein such as chondroitin sulfate synthase 1, which has both beta-1,3-glucuronic acid and beta-1,4-N-acetylgalactosamine transferase activity

EC:  2.4.1.-
Gene Ontology:  GO:0008376
SCOP:  3000077

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
CHGN pfam05679
Chondroitin N-acetylgalactosaminyltransferase;
238-777 0e+00

Chondroitin N-acetylgalactosaminyltransferase;


:

Pssm-ID: 461712 [Multi-domain]  Cd Length: 500  Bit Score: 722.12  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   238 HIGKCLREMYTTHEDVEVGRCVRRFAGVQCVWSYEMQQLFYENYEQNKKGYIRDLHNSKIHQAITLHPNKNPPYQYRLHS 317
Cdd:pfam05679   1 HLDWCLKNLYSTHEDVELGRCIQKFAGIPCTWSYEGQRYFYFNYSSGKKGFIGNLKSKEFHSAITLHPVKDPADMYRLHK 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   318 YMLSRKISELRHRTIQLHREIVLMSKYSNTEIHKEDLQLGIPPSFMRfqPRQREEILEWEFLTGKYLYSAVDGQpPRRGM 397
Cdd:pfam05679  81 YFLSLELQKLRQEIIKLQREIKNMSELLPEGIDSLSWPLGIPPPLNR--PKSRFDVLRWDYFTETHLYSADDGQ-PRRRL 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   398 DSAQREALDDIVMQVMEMINANAKTRGRIIDFKEIQYGYRRVNPMYGAEYILDLLLLYKKHKGKkmTVPVRRHAYLQQTF 477
Cdd:pfam05679 158 DGADKEDLDDVINTAMEEINRNYRPRGRVLEFKQLLNGYRRFDPLRGMEYILDLLLEYKKYRGR--TVPVRRRVYLQRPF 235
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   478 SKIQFVEHEeldaqelakrinqesgslsflsnslkklvpfqlpgsksehKEPKDKKINILIPLSGRFDMFVRFMGNFEKT 557
Cdd:pfam05679 236 SKVEIIPMP----------------------------------------YVTESTRVHIILPLSGRYETFERFLENYERV 275
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   558 CLIPNQNV-KLVVLLFNSD--SNPDKAKQVELMRDYRIKYPKADMQILPVSGEFSRALALEVGSSQFNNESLLFFCDVDL 634
Cdd:pfam05679 276 CLETGENVvLLLVVLYDPDegQNDVFAEIKELIEELEKKYPKAKIPWISVKGEFSRGKALDLGAKKFPPDSLLFFCDVDM 355
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   635 VFTTEFLQRCRANTVLGQQIYFPIIFSQYDPKIVYSGKVP--SDNHFAFTQKTGFWRNYGFGITCIYKGDLVRVGGFDVS 712
Cdd:pfam05679 356 VFTPEFLNRCRMNTIQGKQVYFPIVFSQYDPEVVYYDKPVptSDDNFDISKDTGHWRRYGFGIVCFYKSDYMAVGGFRTS 435
                         490       500       510       520       530       540
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 31542309   713 IQGWGLEDVDLFNKVVQAGLKTFRSQEVGVVHVHHPVFCDPNLDPKQYKMCLGSKASTYGSTQQL 777
Cdd:pfam05679 436 IQGWGLEDVDLYDKFVKSGLHVFRAVEPGLVHRYHPRHCDPRLSEKQYHMCLGSKAEGLASRTQL 500
Galactosyl_T super family cl21608
Galactosyltransferase; This family includes the galactosyltransferases UDP-galactose: ...
87-308 1.88e-14

Galactosyltransferase; This family includes the galactosyltransferases UDP-galactose:2-acetamido-2-deoxy-D-glucose3beta-galactosyltransferase and UDP-Gal:beta-GlcNAc beta 1,3-galactosyltranferase. Specific galactosyltransferases transfer galactose to GlcNAc terminal chains in the synthesis of the lacto-series oligosaccharides types 1 and 2.


The actual alignment was detected with superfamily member pfam02434:

Pssm-ID: 473923  Cd Length: 248  Bit Score: 73.89  E-value: 1.88e-14
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309    87 LFVGVMTAQKYLQTRAVAAYRTWSKTIPgKVQFFSSEGSDTSVPI-----PVVPlrGVDDSYPPQKKSFMMLKyMHDHYL 161
Cdd:pfam02434   6 IFIAVKTTKKFHKTRLPLLLKTWISRAK-HQTYIFTDGEDEGLPTrtgghLINT--NCSAGHCRKALSCKMAV-EYDRFL 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   162 -DKYEWFMRADDDVYIKGDRLENFLRSLNSSEPLFLGQT---GLGTTEEMGKLALEPGENFCMGGPGVIMSREVLRRMVP 237
Cdd:pfam02434  82 eSGKKWFCHVDDDNYVNVPRLVRLLSCYNHTQDVYLGKPslyRPIEATERVKGNRKVGFWFATGGAGFCISRGLALKMSP 161
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   238 HIGKClrEMYTT------HEDVEVGRCVRRFAGVQCVWSyemqQLFYENYEQnkkgyIRDLHNSKIHQAITL----HPNK 307
Cdd:pfam02434 162 WASGG--RFMSTsekirlPDDCTLGYIIENLLGVPLTHS----PLFHSHLEN-----LQDLPPETLHEQVTLsygkFWNK 230

                  .
gi 31542309   308 N 308
Cdd:pfam02434 231 R 231
 
Name Accession Description Interval E-value
CHGN pfam05679
Chondroitin N-acetylgalactosaminyltransferase;
238-777 0e+00

Chondroitin N-acetylgalactosaminyltransferase;


Pssm-ID: 461712 [Multi-domain]  Cd Length: 500  Bit Score: 722.12  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   238 HIGKCLREMYTTHEDVEVGRCVRRFAGVQCVWSYEMQQLFYENYEQNKKGYIRDLHNSKIHQAITLHPNKNPPYQYRLHS 317
Cdd:pfam05679   1 HLDWCLKNLYSTHEDVELGRCIQKFAGIPCTWSYEGQRYFYFNYSSGKKGFIGNLKSKEFHSAITLHPVKDPADMYRLHK 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   318 YMLSRKISELRHRTIQLHREIVLMSKYSNTEIHKEDLQLGIPPSFMRfqPRQREEILEWEFLTGKYLYSAVDGQpPRRGM 397
Cdd:pfam05679  81 YFLSLELQKLRQEIIKLQREIKNMSELLPEGIDSLSWPLGIPPPLNR--PKSRFDVLRWDYFTETHLYSADDGQ-PRRRL 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   398 DSAQREALDDIVMQVMEMINANAKTRGRIIDFKEIQYGYRRVNPMYGAEYILDLLLLYKKHKGKkmTVPVRRHAYLQQTF 477
Cdd:pfam05679 158 DGADKEDLDDVINTAMEEINRNYRPRGRVLEFKQLLNGYRRFDPLRGMEYILDLLLEYKKYRGR--TVPVRRRVYLQRPF 235
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   478 SKIQFVEHEeldaqelakrinqesgslsflsnslkklvpfqlpgsksehKEPKDKKINILIPLSGRFDMFVRFMGNFEKT 557
Cdd:pfam05679 236 SKVEIIPMP----------------------------------------YVTESTRVHIILPLSGRYETFERFLENYERV 275
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   558 CLIPNQNV-KLVVLLFNSD--SNPDKAKQVELMRDYRIKYPKADMQILPVSGEFSRALALEVGSSQFNNESLLFFCDVDL 634
Cdd:pfam05679 276 CLETGENVvLLLVVLYDPDegQNDVFAEIKELIEELEKKYPKAKIPWISVKGEFSRGKALDLGAKKFPPDSLLFFCDVDM 355
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   635 VFTTEFLQRCRANTVLGQQIYFPIIFSQYDPKIVYSGKVP--SDNHFAFTQKTGFWRNYGFGITCIYKGDLVRVGGFDVS 712
Cdd:pfam05679 356 VFTPEFLNRCRMNTIQGKQVYFPIVFSQYDPEVVYYDKPVptSDDNFDISKDTGHWRRYGFGIVCFYKSDYMAVGGFRTS 435
                         490       500       510       520       530       540
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 31542309   713 IQGWGLEDVDLFNKVVQAGLKTFRSQEVGVVHVHHPVFCDPNLDPKQYKMCLGSKASTYGSTQQL 777
Cdd:pfam05679 436 IQGWGLEDVDLYDKFVKSGLHVFRAVEPGLVHRYHPRHCDPRLSEKQYHMCLGSKAEGLASRTQL 500
Fringe pfam02434
Fringe-like; The drosophila protein fringe (FNG) is a glucosaminyltransferase that controls ...
87-308 1.88e-14

Fringe-like; The drosophila protein fringe (FNG) is a glucosaminyltransferase that controls the response of the Notch receptor to specific ligands. FNG is localized to the Golgi apparatus (not secreted as previously thought). Modification of Notch occurs through glycosylation by FNG. The xenopus homolog, lunatic fringe, has been implicated in a variety of functions.


Pssm-ID: 367085  Cd Length: 248  Bit Score: 73.89  E-value: 1.88e-14
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309    87 LFVGVMTAQKYLQTRAVAAYRTWSKTIPgKVQFFSSEGSDTSVPI-----PVVPlrGVDDSYPPQKKSFMMLKyMHDHYL 161
Cdd:pfam02434   6 IFIAVKTTKKFHKTRLPLLLKTWISRAK-HQTYIFTDGEDEGLPTrtgghLINT--NCSAGHCRKALSCKMAV-EYDRFL 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   162 -DKYEWFMRADDDVYIKGDRLENFLRSLNSSEPLFLGQT---GLGTTEEMGKLALEPGENFCMGGPGVIMSREVLRRMVP 237
Cdd:pfam02434  82 eSGKKWFCHVDDDNYVNVPRLVRLLSCYNHTQDVYLGKPslyRPIEATERVKGNRKVGFWFATGGAGFCISRGLALKMSP 161
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   238 HIGKClrEMYTT------HEDVEVGRCVRRFAGVQCVWSyemqQLFYENYEQnkkgyIRDLHNSKIHQAITL----HPNK 307
Cdd:pfam02434 162 WASGG--RFMSTsekirlPDDCTLGYIIENLLGVPLTHS----PLFHSHLEN-----LQDLPPETLHEQVTLsygkFWNK 230

                  .
gi 31542309   308 N 308
Cdd:pfam02434 231 R 231
GT2_Chondriotin_Pol_N cd06420
N-terminal domain of Chondroitin polymerase functions as a GalNAc transferase; Chondroitin ...
699-737 9.10e-03

N-terminal domain of Chondroitin polymerase functions as a GalNAc transferase; Chondroitin polymerase is a two domain, bi-functional protein. The N-terminal domain functions as a GalNAc transferase. The bacterial chondroitin polymerase catalyzes elongation of the chondroitin chain by alternatively transferring the GlcUA and GalNAc moiety from UDP-GlcUA and UDP-GalNAc to the non-reducing ends of the chondroitin chain. The enzyme consists of N-terminal and C-terminal domains in which the two active sites catalyze the addition of GalNAc and GlcUA, respectively. Chondroitin chains range from 40 to over 100 repeating units of the disaccharide. Sulfated chondroitins are involved in the regulation of various biological functions such as central nervous system development, wound repair, infection, growth factor signaling, and morphogenesis, in addition to its conventional structural roles. In Caenorhabditis elegans, chondroitin is an essential factor for the worm to undergo cytokinesis and cell division. Chondroitin is synthesized as proteoglycans, sulfated and secreted to the cell surface or extracellular matrix.


Pssm-ID: 133042 [Multi-domain]  Cd Length: 182  Bit Score: 37.94  E-value: 9.10e-03
                        10        20        30
                ....*....|....*....|....*....|....*....
gi 31542309 699 YKGDLVRVGGFDVSIQGWGLEDVDLFNKVVQAGLKTFRS 737
Cdd:cd06420 134 WKKDLLAVNGFDEEFTGWGGEDSELVARLLNSGIKFRKL 172
 
Name Accession Description Interval E-value
CHGN pfam05679
Chondroitin N-acetylgalactosaminyltransferase;
238-777 0e+00

Chondroitin N-acetylgalactosaminyltransferase;


Pssm-ID: 461712 [Multi-domain]  Cd Length: 500  Bit Score: 722.12  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   238 HIGKCLREMYTTHEDVEVGRCVRRFAGVQCVWSYEMQQLFYENYEQNKKGYIRDLHNSKIHQAITLHPNKNPPYQYRLHS 317
Cdd:pfam05679   1 HLDWCLKNLYSTHEDVELGRCIQKFAGIPCTWSYEGQRYFYFNYSSGKKGFIGNLKSKEFHSAITLHPVKDPADMYRLHK 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   318 YMLSRKISELRHRTIQLHREIVLMSKYSNTEIHKEDLQLGIPPSFMRfqPRQREEILEWEFLTGKYLYSAVDGQpPRRGM 397
Cdd:pfam05679  81 YFLSLELQKLRQEIIKLQREIKNMSELLPEGIDSLSWPLGIPPPLNR--PKSRFDVLRWDYFTETHLYSADDGQ-PRRRL 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   398 DSAQREALDDIVMQVMEMINANAKTRGRIIDFKEIQYGYRRVNPMYGAEYILDLLLLYKKHKGKkmTVPVRRHAYLQQTF 477
Cdd:pfam05679 158 DGADKEDLDDVINTAMEEINRNYRPRGRVLEFKQLLNGYRRFDPLRGMEYILDLLLEYKKYRGR--TVPVRRRVYLQRPF 235
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   478 SKIQFVEHEeldaqelakrinqesgslsflsnslkklvpfqlpgsksehKEPKDKKINILIPLSGRFDMFVRFMGNFEKT 557
Cdd:pfam05679 236 SKVEIIPMP----------------------------------------YVTESTRVHIILPLSGRYETFERFLENYERV 275
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   558 CLIPNQNV-KLVVLLFNSD--SNPDKAKQVELMRDYRIKYPKADMQILPVSGEFSRALALEVGSSQFNNESLLFFCDVDL 634
Cdd:pfam05679 276 CLETGENVvLLLVVLYDPDegQNDVFAEIKELIEELEKKYPKAKIPWISVKGEFSRGKALDLGAKKFPPDSLLFFCDVDM 355
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   635 VFTTEFLQRCRANTVLGQQIYFPIIFSQYDPKIVYSGKVP--SDNHFAFTQKTGFWRNYGFGITCIYKGDLVRVGGFDVS 712
Cdd:pfam05679 356 VFTPEFLNRCRMNTIQGKQVYFPIVFSQYDPEVVYYDKPVptSDDNFDISKDTGHWRRYGFGIVCFYKSDYMAVGGFRTS 435
                         490       500       510       520       530       540
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 31542309   713 IQGWGLEDVDLFNKVVQAGLKTFRSQEVGVVHVHHPVFCDPNLDPKQYKMCLGSKASTYGSTQQL 777
Cdd:pfam05679 436 IQGWGLEDVDLYDKFVKSGLHVFRAVEPGLVHRYHPRHCDPRLSEKQYHMCLGSKAEGLASRTQL 500
Fringe pfam02434
Fringe-like; The drosophila protein fringe (FNG) is a glucosaminyltransferase that controls ...
87-308 1.88e-14

Fringe-like; The drosophila protein fringe (FNG) is a glucosaminyltransferase that controls the response of the Notch receptor to specific ligands. FNG is localized to the Golgi apparatus (not secreted as previously thought). Modification of Notch occurs through glycosylation by FNG. The xenopus homolog, lunatic fringe, has been implicated in a variety of functions.


Pssm-ID: 367085  Cd Length: 248  Bit Score: 73.89  E-value: 1.88e-14
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309    87 LFVGVMTAQKYLQTRAVAAYRTWSKTIPgKVQFFSSEGSDTSVPI-----PVVPlrGVDDSYPPQKKSFMMLKyMHDHYL 161
Cdd:pfam02434   6 IFIAVKTTKKFHKTRLPLLLKTWISRAK-HQTYIFTDGEDEGLPTrtgghLINT--NCSAGHCRKALSCKMAV-EYDRFL 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   162 -DKYEWFMRADDDVYIKGDRLENFLRSLNSSEPLFLGQT---GLGTTEEMGKLALEPGENFCMGGPGVIMSREVLRRMVP 237
Cdd:pfam02434  82 eSGKKWFCHVDDDNYVNVPRLVRLLSCYNHTQDVYLGKPslyRPIEATERVKGNRKVGFWFATGGAGFCISRGLALKMSP 161
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 31542309   238 HIGKClrEMYTT------HEDVEVGRCVRRFAGVQCVWSyemqQLFYENYEQnkkgyIRDLHNSKIHQAITL----HPNK 307
Cdd:pfam02434 162 WASGG--RFMSTsekirlPDDCTLGYIIENLLGVPLTHS----PLFHSHLEN-----LQDLPPETLHEQVTLsygkFWNK 230

                  .
gi 31542309   308 N 308
Cdd:pfam02434 231 R 231
Glyco_transf_7C pfam02709
N-terminal domain of galactosyltransferase; This is the N-terminal domain of a family of ...
688-736 7.02e-06

N-terminal domain of galactosyltransferase; This is the N-terminal domain of a family of galactosyltransferases from a wide range of Metazoa with three related galactosyltransferases activities, all three of which are possessed by one sequence in some cases. EC:2.4.1.90, N-acetyllactosamine synthase; EC:2.4.1.38, Beta-N-acetylglucosaminyl-glycopeptide beta-1,4- galactosyltransferase; and EC:2.4.1.22 Lactose synthase. Note that N-acetyllactosamine synthase is a component of Lactose synthase along with alpha-lactalbumin, in the absence of alpha-lactalbumin EC:2.4.1.90 is the catalyzed reaction.


Pssm-ID: 460659 [Multi-domain]  Cd Length: 78  Bit Score: 44.52  E-value: 7.02e-06
                          10        20        30        40
                  ....*....|....*....|....*....|....*....|....*....
gi 31542309   688 WRNYGFGITCIYKGDLVRVGGFDVSIQGWGLEDVDLFNKVVQAGLKTFR 736
Cdd:pfam02709  16 YKTYFGGVLALSREDFERINGFSNGFWGWGGEDDDLYNRLLLAGLEIER 64
GT2_Chondriotin_Pol_N cd06420
N-terminal domain of Chondroitin polymerase functions as a GalNAc transferase; Chondroitin ...
699-737 9.10e-03

N-terminal domain of Chondroitin polymerase functions as a GalNAc transferase; Chondroitin polymerase is a two domain, bi-functional protein. The N-terminal domain functions as a GalNAc transferase. The bacterial chondroitin polymerase catalyzes elongation of the chondroitin chain by alternatively transferring the GlcUA and GalNAc moiety from UDP-GlcUA and UDP-GalNAc to the non-reducing ends of the chondroitin chain. The enzyme consists of N-terminal and C-terminal domains in which the two active sites catalyze the addition of GalNAc and GlcUA, respectively. Chondroitin chains range from 40 to over 100 repeating units of the disaccharide. Sulfated chondroitins are involved in the regulation of various biological functions such as central nervous system development, wound repair, infection, growth factor signaling, and morphogenesis, in addition to its conventional structural roles. In Caenorhabditis elegans, chondroitin is an essential factor for the worm to undergo cytokinesis and cell division. Chondroitin is synthesized as proteoglycans, sulfated and secreted to the cell surface or extracellular matrix.


Pssm-ID: 133042 [Multi-domain]  Cd Length: 182  Bit Score: 37.94  E-value: 9.10e-03
                        10        20        30
                ....*....|....*....|....*....|....*....
gi 31542309 699 YKGDLVRVGGFDVSIQGWGLEDVDLFNKVVQAGLKTFRS 737
Cdd:cd06420 134 WKKDLLAVNGFDEEFTGWGGEDSELVARLLNSGIKFRKL 172
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH